1. Home
  2. TNL vs ABCL Comparison

TNL vs ABCL Comparison

Compare TNL & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Travel   Leisure Co.

TNL

Travel Leisure Co.

N/A

Current Price

$75.61

Market Cap

3.9B

ML Signal

N/A

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

N/A

Current Price

$11.16

Market Cap

4.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TNL
ABCL
Founded
1990
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.9B
4.1B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
TNL
ABCL
Price
$75.61
$11.16
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
13
Target Price
★ $87.23
$17.17
AVG Volume (30 Days)
712.8K
★ 4.3M
Earning Date
10-27-2026
11-09-2026
Dividend Yield
★ 3.35%
N/A
EPS Growth
N/A
★ 10.91
EPS
★ 4.66
N/A
Revenue
★ $4,021,000,000.00
$75,128,000.00
Revenue This Year
$4.45
N/A
Revenue Next Year
$5.26
$7.12
P/E Ratio
$15.30
★ N/A
Revenue Growth
4.06
★ 160.56
52 Week Low
$60.34
$2.75
52 Week High
$81.00
$14.98

Technical Indicators

Market Signals
Indicator
TNL
ABCL
Relative Strength Index (RSI) 76.73 42.95
Support Level $71.82 $10.61
Resistance Level $79.28 $12.88
Average True Range (ATR) 2.09 0.87
MACD 1.15 -0.07
Stochastic Oscillator 94.32 10.43

Price Performance

Historical Comparison
TNL
ABCL

About TNL Travel Leisure Co.

Travel+Leisure Co is a membership and leisure travel company. It provides hospitality services and travel products. The company operates in the segments of Vacation Ownership, which is the key revenue-driving segment, develops, markets and sells vacation ownership interests (VOIs) to individual consumers, provides consumer financing in connection with the sale of VOIs, and provides property management services at resorts, and Travel and Membership which operates a variety of travel businesses, including two vacation exchange brands, Vacation Ownership and Travel and Membership The majority of the revenue is earned from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: